scispace - formally typeset
Search or ask a question
Institution

Eppley Institute for Research in Cancer and Allied Diseases

About: Eppley Institute for Research in Cancer and Allied Diseases is a based out in . It is known for research contribution in the topics: Pancreatic cancer & Cancer. The organization has 965 authors who have published 1396 publications receiving 58994 citations.
Topics: Pancreatic cancer, Cancer, DNA, Gene, Cancer cell


Papers
More filters
Journal ArticleDOI
TL;DR: Results suggest that expression of MUC4 in ICC‐MF is a new independent factor for poor prognosis and is a useful marker to predict the outcome of the patients with ICC‐ MF.

123 citations

Journal ArticleDOI
13 Nov 2014-Oncogene
TL;DR: It is shown that expression of microRNA (miR)-192 is inversely correlated with metastatic potential of colon cancer cells and restoration of miR-192 expression or antagonism of its target genes (Bcl-2, Zeb2 or VEGFA) may have considerable therapeutic potential for anti-metastatic therapy in patients with colon cancer.
Abstract: Metastasis causes most deaths from colon cancer yet mechanistic understanding and therapeutic options remain limited. Here we show that expression of microRNA (miR)-192 is inversely correlated with metastatic potential of colon cancer cells. Ectopic expression of miR-192 sensitizes colon cancer cells to growth factor deprivation stress-induced apoptosis, whereas inhibition of miR-192 confers resistance. Overexpression of miR-192 inhibits metastatic colonization to the liver in an orthotopic mouse model of colon cancer. Alterations associated with the metastatic phenotype in the primary tumors include increased apoptosis, decreased proliferation and angiogenesis. Further studies indicate that miR-192 downregulates expression of Bcl-2, Zeb2 and VEGFA in vitro and in vivo, which is responsible for enhanced apoptosis, increased expression of E-cadherin and decreased angiogenesis in vivo, respectively. Finally, studies performed on human colonic adenocarcinoma show that expression of miR-192 is significantly reduced in neoplastic cells as compared with normal colonic epithelium. Importantly, there is a significant decrease in miR-192 expression in stage IV tumors when compared with stage I or II lesions. These findings indicate that miR-192 has an important role in colon cancer development and progression. Our studies underscore the clinical relevance and prognostic significance of miR-192 expression in colon cancer. Therefore, a major implication of our studies is that restoration of miR-192 expression or antagonism of its target genes (Bcl-2, Zeb2 or VEGFA) may have considerable therapeutic potential for anti-metastatic therapy in patients with colon cancer.

122 citations

Journal ArticleDOI
TL;DR: The role of MUC16 under normal physiological conditions and during tumorigenesis is described and the role of anti-MUC16 therapy trials that are currently in the initial phases of clinical testing are discussed.
Abstract: Introduction: MUC16 is overexpressed in multiple cancers and plays an important role in tumorigenicity and acquired resistance to therapy.Area covered: In this review, we describe the role of MUC16...

121 citations

Journal ArticleDOI
TL;DR: It is demonstrated that fatty acid biosynthesis pathway manipulation can help overcome the gemcitabine resistance in pancreatic cancer by regulating ER stress and stemness.
Abstract: Pancreatic adenocarcinoma is moderately responsive to gemcitabine-based chemotherapy, the most widely used single-agent therapy for pancreatic cancer. Although the prognosis in pancreatic cancer remains grim in part due to poor response to therapy, previous attempts at identifying and targeting the resistance mechanisms have not been very successful. By leveraging The Cancer Genome Atlas dataset, we identified lipid metabolism as the metabolic pathway that most significantly correlated with poor gemcitabine response in pancreatic cancer patients. Furthermore, we investigated the relationship between alterations in lipogenesis pathway and gemcitabine resistance by utilizing tissues from the genetically engineered mouse model and human pancreatic cancer patients. We observed a significant increase in fatty acid synthase (FASN) expression with increasing disease progression in spontaneous pancreatic cancer mouse model, and a correlation of high FASN expression with poor survival in patients and poor gemcitabine responsiveness in cell lines. We observed a synergistic effect of FASN inhibitors with gemcitabine in pancreatic cancer cells in culture and orthotopic implantation models. Combination of gemcitabine and the FASN inhibitor orlistat significantly diminished stemness, in part due to induction of endoplasmic reticulum (ER) stress that resulted in apoptosis. Moreover, direct induction of ER stress with thapsigargin caused a similar decrease in stemness and showed synergistic activity with gemcitabine. Our in vivo studies with orthotopic implantation models demonstrated a robust increase in gemcitabine responsiveness upon inhibition of fatty acid biosynthesis with orlistat. Altogether, we demonstrate that fatty acid biosynthesis pathway manipulation can help overcome the gemcitabine resistance in pancreatic cancer by regulating ER stress and stemness. Cancer Res; 77(20); 5503-17. ©2017 AACR.

120 citations

Journal ArticleDOI
TL;DR: The laser scanning confocal microscopy performed to assess the associated neuronal damage showed that microtubule associated protein-2 (MAP-2) immunoreactive dendrites were significantly reduced in both the ipsilateral and contralateral hemispheres of encephalitic mice.
Abstract: The human immunodeficiency virus type 1 (HIV)-associated dementia complex (ADC) is a neuroimmunological disorder fueled by viral replication in mononuclear phagocytes (MP) (brain macrophages and mi...

120 citations


Authors

Showing all 965 results

NameH-indexPapersCitations
Michael R. Green12653757447
Henrik Clausen10952049820
Howard E. Gendelman10156739460
James O. Armitage9755859171
Surinder K. Batra8756430653
Michael L. Gross8270127140
Michael A. Hollingsworth7624924460
Peter M. J. Burgers7316716123
Patrick L. Iversen6831913707
J. Alan Diehl6716819966
Samuel M. Cohen6542115940
Kenneth H. Cowan6417814094
Gangning Liang6015018081
Michael G. Brattain5919913199
Thomas E. Smithgall571848904
Network Information
Related Institutions (5)
National Institutes of Health
297.8K papers, 21.3M citations

94% related

Laboratory of Molecular Biology
24.2K papers, 2.1M citations

91% related

Scripps Research Institute
32.8K papers, 2.9M citations

91% related

Albert Einstein College of Medicine
56.4K papers, 2.7M citations

90% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

90% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20223
202188
202069
201964
201842
201757